HALE DAVID F
SEC insider (Form 3/4/5 filer). CIK 0001024004. Director at Dermata Therapeutics, Inc. (DRMA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.
Companies HALE DAVID F has filed insider reports for
- Dermata Therapeutics, Inc. (DRMA): Director
HALE DAVID F
CIK: 0001024004
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dermata Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.5K shares- - Jan 23, 2025DRMA
Dermata Therapeutics, Inc.
AwardIndirect78.7K shares- - Jan 21, 2025DRMA
Dermata Therapeutics, Inc.
AwardIndirectWarrant (Right to Buy)
78.7K shares- - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,500 | - | - | Direct |
| Jan 23, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 78,741 | - | $0 | Indirect |
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | Award Warrant (Right to Buy) | 78,741 | - | - | Indirect |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,000 | - | - | Direct |
1-4 of 4 transactions